NEW YORK--(BUSINESS WIRE)--
(NASDAQ:MDSO), the leading global provider of cloud-based technology and
data analytics for clinical research, today announced that the company
will present at the following upcoming investor conferences.
Rouven Bergmann, chief financial officer, will present at the
Jefferies Technology Group 2017 Global Technology Conference on
Tuesday, May 9, 2017, at 4:00 p.m. ET in Miami.
Rouven Bergmann, chief financial officer, will present at the Needham
Emerging Technology Conference on Tuesday, May 16, 2017, at 8:00 a.m.
ET in New York.
Tarek Sherif, chief executive officer, will present at the J.P. Morgan
45th Annual Global Technology, Media and Telecom Conference on Monday,
May 22, 2017, at 3:00 p.m. ET in Boston.
A live audio webcast will be available on the "Investor" section of
Medidata's website at http://investor.mdsol.com.
Please visit the website at least 15 minutes prior to the event to
register, download and install any necessary audio or video software to
access the presentation. For those unable to participate in the live
webcast, a replay will be archived on the "Investor" section of
Medidata's website at http://investor.mdsol.com
for a limited period of time following the conference.
is reinventing global drug and medical device development by creating
the industry's leading cloud-based solutions for clinical research.
Through our advanced applications and intelligent data analytics,
Medidata helps advance the scientific goals of life sciences customers
worldwide, including over 850 global pharmaceutical companies, biotech,
diagnostic and device firms, leading academic medical centers, and
contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality
and efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled clinical
trial data assets provide deep insights that pave the way for future
growth. The Medidata Clinical Cloud is the primary technology solution
powering clinical trials for 18 of the world's top 25 global
pharmaceutical companies and is used by 16 of the top 20 medical device
developers—from study design and planning through execution, management
View source version on businesswire.com: http://www.businesswire.com/news/home/20170503005496/en/
News Provided by Acquire Media